Pupil Bio is a cutting-edge biotechnology company focused on developing advanced neurotechnology solutions, particularly in the realm of brain-computer interfaces (BCIs). The company leverages innovative research and engineering to create devices that enhance human cognitive functions and address neurological disorders. Pupil Bio generates revenue through the commercialization of its proprietary BCI technologies, partnerships with healthcare providers, and licensing agreements with tech and medical firms. Founded by a team of neuroscientists and engineers, the company has gained attention for its groundbreaking contributions to the intersection of neuroscience and technology. Candidates should note its emphasis on innovation, collaboration, and its mission to improve human health and potential.